A sponsor initiates a multi-site trial and selects investiga…
A sponsor initiates a multi-site trial and selects investigators based primarily on prior enrollment performance, without reviewing their experience with the investigational product’s therapeutic area. Which regulatory obligation is most at risk of being inadequately fulfilled?
Read Details